MicroPort CardioFlow Medtech Corporation (FRA:72X)
Germany · Delayed Price · Currency is EUR 0.1250
-0.0020 (-1.57%)
At close: Nov 28, 2025
FRA:72X Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| 367.53 | 361.57 | 336.22 | 251.03 | 200.81 | 103.93 | Upgrade | |
Revenue Growth (YoY) | -4.02% | 7.54% | 33.94% | 25.00% | 93.21% | 383.37% | Upgrade |
Cost of Revenue | 113.62 | 110.36 | 106.28 | 88.9 | 82.11 | 58.55 | Upgrade |
Gross Profit | 253.91 | 251.21 | 229.93 | 162.13 | 118.7 | 45.38 | Upgrade |
Selling, General & Admin | 221.73 | 222.44 | 293.23 | 232.77 | 151.77 | 96.58 | Upgrade |
Research & Development | 121.73 | 153.41 | 237.34 | 223.78 | 151.13 | 96.84 | Upgrade |
Other Operating Expenses | 8.34 | 13.22 | 101.2 | 71.42 | -4.39 | 102.08 | Upgrade |
Operating Expenses | 351.79 | 389.08 | 631.77 | 527.97 | 298.52 | 295.5 | Upgrade |
Operating Income | -97.88 | -137.87 | -401.84 | -365.84 | -179.82 | -250.12 | Upgrade |
Interest Expense | -4.85 | -3.78 | -3.92 | -5.19 | -19.64 | -146.15 | Upgrade |
Interest & Investment Income | 66.99 | 75.91 | 86.54 | 38.64 | 24.71 | 5.22 | Upgrade |
Earnings From Equity Investments | -37.83 | -61.67 | -64.46 | -69.31 | -3.51 | 0.72 | Upgrade |
Currency Exchange Gain (Loss) | 1.25 | 0.02 | 1.58 | -0.25 | -3.57 | -7.6 | Upgrade |
Other Non Operating Income (Expenses) | -0.27 | -0.23 | -0.23 | -0.22 | -0.26 | -0.16 | Upgrade |
EBT Excluding Unusual Items | -72.58 | -127.61 | -382.32 | -402.17 | -182.08 | -398.09 | Upgrade |
Gain (Loss) on Sale of Investments | 82.03 | 82.03 | -81.33 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.69 | -0.69 | 0.07 | -0.03 | -0.57 | - | Upgrade |
Asset Writedown | - | - | - | -49.1 | - | - | Upgrade |
Pretax Income | 8.76 | -46.26 | -463.58 | -451.3 | -182.65 | -398.09 | Upgrade |
Income Tax Expense | 6.47 | 7.01 | 7.95 | 3.1 | 0.61 | - | Upgrade |
Earnings From Continuing Operations | 2.29 | -53.27 | -471.53 | -454.4 | -183.26 | -398.09 | Upgrade |
Minority Interest in Earnings | 2.56 | 3.82 | - | - | - | - | Upgrade |
Net Income | 4.85 | -49.45 | -471.53 | -454.4 | -183.26 | -398.09 | Upgrade |
Net Income to Common | 4.85 | -49.45 | -471.53 | -454.4 | -183.26 | -398.09 | Upgrade |
Shares Outstanding (Basic) | 2,329 | 2,339 | 2,363 | 2,366 | 2,331 | 1,714 | Upgrade |
Shares Outstanding (Diluted) | 2,329 | 2,339 | 2,363 | 2,366 | 2,331 | 1,714 | Upgrade |
Shares Change (YoY) | -1.13% | -1.02% | -0.11% | 1.47% | 36.04% | -2.08% | Upgrade |
EPS (Basic) | 0.00 | -0.02 | -0.20 | -0.19 | -0.08 | -0.23 | Upgrade |
EPS (Diluted) | 0.00 | -0.02 | -0.20 | -0.19 | -0.08 | -0.23 | Upgrade |
Free Cash Flow | -424.86 | -269.89 | -234.91 | -228.47 | -244.92 | -141.36 | Upgrade |
Free Cash Flow Per Share | -0.18 | -0.12 | -0.10 | -0.10 | -0.10 | -0.08 | Upgrade |
Gross Margin | 69.08% | 69.48% | 68.39% | 64.59% | 59.11% | 43.66% | Upgrade |
Operating Margin | -26.63% | -38.13% | -119.52% | -145.74% | -89.54% | -240.65% | Upgrade |
Profit Margin | 1.32% | -13.68% | -140.25% | -181.01% | -91.26% | -383.02% | Upgrade |
Free Cash Flow Margin | -115.60% | -74.65% | -69.87% | -91.02% | -121.97% | -136.01% | Upgrade |
EBITDA | -66.08 | -108.74 | -377.29 | -347.91 | -173.99 | -246.97 | Upgrade |
EBITDA Margin | -17.98% | -30.08% | -112.22% | -138.60% | -86.64% | -237.62% | Upgrade |
D&A For EBITDA | 31.81 | 29.12 | 24.55 | 17.93 | 5.83 | 3.15 | Upgrade |
EBIT | -97.88 | -137.87 | -401.84 | -365.84 | -179.82 | -250.12 | Upgrade |
EBIT Margin | -26.63% | -38.13% | -119.52% | -145.74% | -89.54% | -240.65% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.